Role for transforming growth factor-β1 in Alport renal disease progression

Kidney International

Volumn 56, Issue 5, 1999, Pages 1662-1673

  Sayers, Robinlyn ^a,b,c,d   Kalluri, Raghuram ^a,b,c,d   Rodgers, Kathyrn D ^a,b,c,d   Shield III, Charles F ^a,b,c,d   Meehan, Daniel T ^a,b,c,d   Cosgrove, Dominic ^a,b,c,d  

^a BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Via Christi Rehabilitation Center   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alport syndrome; Diabetes; Extracellular matrix; IDDM; TGF

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ALPORT SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE COURSE; GLOMERULONEPHRITIS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 0032701879     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00744.x     Document Type: Article

References (44)

1. 1. TRYGGVASON K, ZHOU J, HOSTIKKA SL, SHOWS TB: Molecular genetics of Alport syndrome. Kidney Int 43:38-44, 1993
2. 2. KLEPPEL MM, SANTI PA, CAMERON JD, WIESLANDER J, MICHAEL: AF: Human tissue distribution of novel basement membrane collagen. Am J Pathol 134:813-825, 1989
3. 3. PIHLAJANIEMI T: Molecular properties of the glomerular basement membrane, in Molecular Pathology and Genetics of Alport Syndrome (vol 188), edited by TRYGGVASON K, Basel, Karger, 1996, pp 46-79
4. 4. GUNWAR S, BALLESTER F, KALLURI R, TIMONEDA J, CHONKO AM, EDWARDS SJ, NOELKEN ME, HUDSON BG: Gomerular basement membrane. Identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the Goodpasture antigen. J Biol Chem 266:15318-15324, 1991
5. 5. GUNWAR S, BALLESTER F, NOELKEN ME, NINOMIVA Y, HUDSON B: Glomerular basement membrane: Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome. J Biol Chem 273:8767-8775, 1998
6. 6. KLEPPEL MM, FAN WW, CHEONG HI, MICHAEL AF: Evidence for separate networks of classical and novel basement membrane collagen. J Biol Chem 267:4137-4142, 1992
7. 7. MINER JH, SANES JR: Collagen IV α3, α4, and α5 chains in rodent basal lamina: Sequence, distribution, association with laminins, and developmental switches. J Cell Biol 127:879-891, 1994
8. 8. KALLURI R, SHIELD CF III, TODD P, HUDSON BG, NIELSON EG: Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 99:2470-2478, 1997
9. 9. HARVEY SJ, ZHENG K, SADO Y, NAITO I, NINOMIYA Y, JACOBS RM, HUDSON BG, THORNER PS: Role of distinct type IV collagen networks in glomerular development and function. Kidney Int 54:1857-1866, 1998
10. 10. ATKIN CL, GREGORY MC, BORDER WA: Alport syndrome, in Diseases of the Kidney, edited by SCHRIER RW, GOTTSCHALK CW, Boston, Little, Brown, 1988, pp 617-641
11. 11. WESTER DC, ATKIN CL, GREGORY MC: Alport syndrome: Clinical update. J Am Acad Audiol 6:73-79, 1995
12. 12. BARKER DE, HOSTIKKA SL, ZHOU J, SHOW LT, OLIPHANT AR, GERKEN SC, GREGORY MC, SKOLNICK MH, ATKIN CL, TRYGGVASON K: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-1227, 1990
13. 13. MOCHIZUKI T, LEMMINK HH, MARIYAMA M, ANTIGNAC C, GUBLER M-C, PIRSON Y, VERELLEN-DUMOULIN C, CHAN B, SCHRODER CH, SMEETS HJ, REEDERS ST: Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8:77-82, 1994
14. 14. KASHTAN CE, KIM Y: Distribution of the α1 and α2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 42:115-126, 1992
15. 15. GUBLER M-C, KNEBELMANN B, BEZIAU A, BROYER M, PIRSON Y, HADDOUM F, KLEPPEL MM, ANTIGNAC C: Autosomal recessive Alport syndrome: Immunohistochemical study of type IV collagen chain distribution. Kidney Int 47:1142-1147, 1995
16. 16. MAZZUCCO G, BARSOTTI P, MUDA AO, FORTUNATO M, MIHATSCH M, TORRI-TARELLI L, RENIERI A, FARAGGIANA T, DE MARCHI M, MONGA G: Ultrastructural and immunohistochemical findings in Alport syndrome: A study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J Am Soc Nephrol 9:1023-1031, 1998
17. 17. COSGROVE D, MEEHAN DT, GRUNKEMEYER JA, KORNAK JM, SAYERS R, HUNTER WJ, SAMUELSON GC: Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Dev 10:2981-2992, 1996
18. 18. YAMAMOTO T, NOBLE NA, MILLER DE, BORDER WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
19. 19. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, ROUSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
20. 20. WAGNER C, VIEDT C, BURGER A, FILSINGER S, KRAMER M, HANSCH GM: Interaction of transforming growth factor β1 with human glomerular epithelial cells in culture: Opposite effects on synthesis of matrix proteins and on urokinase plasminogen activator. J Mol Med 74:149-154, 1996
21. 21. MILLER DA, MATSUI Y, CHEN EY, MOSES HL, DERYNCK R: Complementary DNA cloning of the murine transforming growth factor β3 (TGF β3) precursor and the comparative expression of TGF β3 and TGF β1 messenger RNA in murine embryos and adult tissues. Mol Endocrinol 3:1926-1934, 1989
22. 22. DESJARDINS M, BENDAYAN M: Ontogenesis of glomerular basement membrane: Structural and functional properties. J Cell Biol 113:689-700, 1991
23. 23. YANG C-W, VLASSARA H, STRIKER GE, STRIKER LJ: Administration of AGEs in vivo induces genes implicated in diabetic glomerulosclerosis. Kidney Int 47(Suppl):S53-S58, 1995
24. 24. AGAKI Y, ISAKA Y, ARAI M, KANEKO T, TAKENAKA M, MORIYAMA T, KANEDA Y, ANDO A, ORITA Y, KAMADA T, UEDA N, IMAI E: Inhibition of TGF-β1 expression by antisense oligonucleotides: Suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155, 1996
25. 25. PARK I-S, KIYOMOTO H, ABBOUD SL, ABBOUD HE: Expression of transforming growth factor β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473-480, 1997
26. 26. KOYA D, JIROUSEK MR, LIN Y-W, ISHH H, KUBOKI K, KING GR: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
27. 27. VAN-DET NF, VERHAGEN NAM, TAMSMA JT, BERDEN JHM, BRUIJN JA, DAHA MR, VAN DER WOUDE FJ: Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II. Diabetes 46:834-840, 1997
28. 28. KUNCIO GS, ALVAREZ R, LI S, KILLEN PD: Transforming growth factor-β modulation of the α1(IV) collagen gene in murine proximal tubular cells. Am J Physiol 271:F120-F125, 1996
29. 29. MlYAZAWA K, KIKUCHI S, FUKUYAMA J, HAMANO S, UJHE A: Inhibition of PDGF-and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 118:213-221, 1995
30. 30. ANTONVYCH TT, DEASY PF, TINA LU, D'ALBORA JB, HOLERMAN CE, CACAGNO PL: Hereditary nephritis: Early clinical, functional and morphological studies. Pediatr Res 3:545-550, 1969
31. 31. GUBLER M, LEVY M, BROYER M, NAIZOT C, GONZALEZ G, PERRIN D, HABIB R: Alport syndrome: A report of 58 cases and a review of the literature. Am J Med 70:493-505, 1981
32. 32. AHMED Z, LEE J: Asymptomatic urinary anomolies: Hematuria and proteinuria. Med Clin North Am 81:641-652, 1997
33. 1. Exp Cell Res 227:223-229, 1996
34. 34. HEINO J, MASSAGUÉ J: Transforming growth factor-β switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J Biol Chem 264:21806-21811, 1989
35. 35. IGNOTZ RA, HEINO J, MASSAGUÉ J: Regulation of cell adhesion receptors by transforming growth factor-β. J Biol Chem 264:389-392, 1989
36. 36. HEINO J, IGNOTZ RA, HEMLER ME, CROUSE C, MASSAGUÉ J: Regulation of cell adhesion receptors by transforming growth factor-β: Concomitant regulation of integrins that share a common β subunit. J Biol Chem 264:380-388, 1989
37. 37. IGNOTZ RA, MASSAGUÉ J: Cell adhesion protein receptors as targets for transforming growth factor-β action. Cell 51:189-197, 1987
38. 38. BASTA-JOVANOVIC GM, SAVIN AZ, JOVANOVIC R, VELJOVIC M, SINDJIC M: Laminin, fibronectin, and Goodpasture antigen detection in patients with Alport syndrome. Renal Fail 15:503-508, 1993
39. 39. SANES JR, ENGVALL E, BUTKOWSKI R, HUNTER DD: Molecular heterogeneity of basal laminae: Isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol 111:1685-1699, 1990
40. 40. NAKAPOULOU L, STEFANAKI K, ZEIS PM, PAPADAKIS J, BOLETIS J, VOSNIDIS G, DAVARIS P: The glomerular distribution of laminin and fibronectic in glomerulonephritis. Histol Histopathol 8:521-526, 1993
41. 41. FUKATSU A, MATSUO S, KILLEN PD, MARTIN GR, ANDRES GA, BRENTJENS JR: The glomerular distribution of type IV collagen and laminin in human membranous glomerulonephritis. Hum Pathol 19:64-68, 1988
42. 42. IKEYA M, NAGASE N, HONDA N: Intraglomerular distribution of fibronectin in primary glomerular disease. Clin Nephrol 24:53-59, 1985
43. 43. DOI T, VLASSARA H, KIRSTEIN M, YAMADA Y, STRIKER GE, STRIKER LJ: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products as mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 89:2873-2877, 1992
44. 44. YANG C-W, VLASSARA H, PETEN EP, HE C-J, STRIKER GE, STRIKER LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91:9436-9440, 1994